期刊文献+

介入治疗左主干病变合并肾功能轻度下降患者的预后分析

Outcomes after percutaneous cororary intervention for left main coronary artery and mildly impaired renal function
下载PDF
导出
摘要 目的:本研究旨在研究经皮冠状动脉介入术(PCI)治疗左主干病变合并肾功能轻度下降患者的预后。方法:入选北京安贞医院行PCI治疗左主干病变合并肾小球滤过率(eGFR)>60mL·min^(-1)·1.73m^(-2)的患者,分为两组:CKD1期(肾功能正常组):eGFR>90mL·min^(-1)·1.73m^(-2),CKD2期(肾功能轻度下降组):eGFR在60~89 mL·min^(-1)·1.73m^(-2)之间。研究终点包括全因死亡/心肌梗死/卒中联合终点、全因死亡、心肌梗死、卒中、再次血运重建。结果:共入选患者801例,CKD1期410例,CKD2期391例,随访时间中位数5.6(4.4,6.8)年,校正前CKD1期和CKD2期两组间不良事件发生率如下:全因死亡/心肌梗死/卒中(7.3%vs.14.8%,P=0.001)、全因死亡(3.2%vs.8.2%,P=0.002)、卒中(1.5%vs.4.1%,P=0.032)、心肌梗死(4.6%vs.6.9%,P=0.202)、再次血运重建(23.9%vs.22.8%,P=0.995)。Cox多因素校正分析后,校正后各终点差异与校正前趋势相同。结论:肾功能轻度下降的左主干病变患者行PCI治疗较肾功能正常的患者预后差。 Objective:To evaluate the outcomes of patients treated with percutaneous coronary intervention(PCI)for left main coronary artery lesions and mildly impaired renal function.Methods:801 patients with lesions in unprotected left main coronary artery and eGFR>60mL·min^(-1)·1.73m^(-2) were enrolled who underwent PCI in Beijing AnZhen Hospital.The endpoints of the study were death,repeat revascularization,myocardial infarction(MI),stroke and the composite of death,MI and stroke.Results:From January 2003 to July 2009,801 patients with unprotected left main coronary artery disease and eGFR>60 mL·min^(-1)·1.73^(-2)m were enrolled in Beijing An Zhen Hospital(CKD 1 stage 410 vs.CKD 2 stage 391).The median follow-up was 5.6(4.4,6.8)years in the overall patients.The crude relative risk are as follows.The occurrences of death(CKD 1 stage 3.2%vs.CKD 2 stage 8.2%,P=0.002),stroke(CKD 1 stage 1.5%vs.CKD 2 stage 4.1%,P=0.032)and composite of serious outcomes(death,MI,or stroke)(CKD 1 stage 7.3%vs.CKD 2 stage 14.8%,P=0.001)were significantly higher with the CKD 2 stage group.No significant difference was observed in the rate of MI(CKD 1 stage 23.9%vs.CKD 2 stage 22.8%,P=0.202)and repeart revascularization(CKD 1 stage 1.5%vs.CKD 2 stage 4.1%,P=0.995)between the two groups.After multivariate analysis,the trends were the same as the unadjusted results.Conclusions:Compared to the normal renal function and left main coronary artery disease treated with PCI,patients with mildly impaired renal function suffered poorer prognosis.
作者 玉献鹏 吴长燕 李宇 曾勇 YU Xianpeng;WU Changyan;LI Yu;ZENG Yong(Department of Cardiology,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing 100029,China)
出处 《心肺血管病杂志》 CAS 2022年第8期841-844,862,共5页 Journal of Cardiovascular and Pulmonary Diseases
关键词 经皮冠状动脉介入术 左主干病变 预后 Left main coronary artery Percutaneous coronary intervention Prognosis
  • 相关文献

参考文献3

二级参考文献40

  • 1Zhang QL, Brenner H, Koenig W, et al. Prognostic value ofchronic kidney disease in patients with coronary heart disease : roleof estimating equations. Atherosclerosis, 2010,211 : 342-347.
  • 2Waheed S, Matsushita K, Sang Y, et al. Combined association ofalbuminuria and cystatin C-based estimated GFR with mortality,coronary heart disease, and heart failure outcomes: theatherosclerosis risk in communities ( ARIC) study. Am J KidneyDis,2012, 60:207-216.
  • 3Go AS, Chertow GM, Fan D, et al. Chronic kidney disease andthe risks of death, cardiovascular events, and hospitalization. NEngl J Med,2004,351 : 1296-1305.
  • 4Nozue T, Yamamoto S, Tohyama S, et al. Impacts of estimatedglomerular filtration rate on coronary atherosclerosis and plaquecomposition before and during statin therapy in patients withnormal to mild renal dysfunction: subanalysis of the TRUTHstudy. Nephrology (Carlton), 2012,17: 628-635.
  • 5Parikh PB,Jeremias A,Naidu SS,et al. Impact of severity ofrenal dysfunction on determinants of in-hospital mortality amongpatients undergoing percutaneous coronary intervention. CatheterCardiovasc Interv, 2012, 80: 352-357.
  • 6Bax L, Algra A, Mali WP, et al. Renal function as a riskindicator for cardiovascular events in 3216 patients with manifestarterial disease. Atherosclerosis, 2008 , 200 : 184-190.
  • 7Mann JF, Gerstein HC, Pogue J, et al. Renal insufficiency as apredictor of cardiovascular outcomes and the impact of ramipril:the HOPE randomized trial. Ann Intern Med, 2001 , 134: 629-636.
  • 8van Domburg RT,Hoeks SE,Welten GM,et al. Renalinsufficiency and mortality in patients with known or suspectedcoronary artery disease. J Am Soc Nephrol, 2008,19 : 158-163.
  • 9Expert committee on the diagnosis and classification of diabetesmellitus. Report of the expert committee on the diagnosis andclassification of diabetes mellitus. Diabetes Care, 2003,26: S5-20.
  • 10Levey AS, Coresh J, Greene T, et al. Using standardized serumcreatinine values in the modification of diet in renal disease studyequation for estimating glomerular filtration rate. Ann Intern Med,2006,145:247-254.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部